²úÎï·ÖÀà
Product CategoryÏêϸ½éÉÜ
Æ·ÅÆ | ³¢¾±´Ú±ð-¾±³¢²¹²ú/Àî¼ÇÉúÎï |
---|
°ä2°ä12£¨Ð¡Êó³É¼¡Ï¸°û£©ÃèÊö
¡¡¡¡C2C12£¨ÖÐÎÄÃû³Æ£ºÐ¡Êó³É¼¡Ï¸°û£©£¬À´Ô´ÓÚСÊó¼¡È⣬Õý³£µÄϸ°ûÐÎ̬ΪÉÏÆ¤Ñù£¬Ìù±ÚÉú³¤¡£
¶©¹ºÐÅÏ¢
²úÎïÃû³Æ | »õºÅ | ¹æ¸ñ |
C2C12 | AX31L553 | T25/1 mL |
ÔËÊ䷽ʽ
³£ÎÂ/¸É±ùÔËÊä¡£
°ä2°ä12£¨Ð¡Êó³É¼¡Ï¸°û£©Ê¹Ó÷½·¨
ÅàÑø·½·¨
ÅàÑø»ù | DMEM£¨GIBCO: C11965500BT£©90%, Fetal Bovine Serum(GIBCO:10099-141)»òºÍÔªÀî¼ÇÌØ¼¶Ì¥Å£ÑªÇå (Foetal Bovine Serum)£¨»õºÅ£ºAC03L055£© 10% |
ÅàÑøÌõ¼þ | 37¡æ 5% CO2 |
Ïû»¯Ìõ¼þ | 0.25% (w/v) Trypsin-0.53 mM EDTAÈÜÒº£¬Ïû»¯1-3min |
´«´ú±ÈÀý | 1£º3-1£º6 |
»»ÒºÊ±¼ä | 2-3Ìì»»ÒºÒ»´Î |
¶³´æ·½·¨
¶³´æÒº | 55%ÅàÑø»ù£¬40%FBS, 5% (v/v) DMSO »ò ºÍÔªÀî¼Ç¿ìËÙϸ°û¶³´æÒº£¨ÎÞѪÇå¡¢ÎÞµ°°×£©£¨»õºÅ£ºAC05L033£© |
¶³´æÃÜ¶È | 1-3 ¡Á106 /¹Ü£¬Òºµª±£´æ |
¡¡ ¾ßÌå²Ù×÷·½·¨¼ûϸ°ûʹÓÃ˵Ã÷Êé
×¢ÒâÊÂÏî
±¾²úÎï½öÏÞÓÚ¿ÆÑ§ÊµÑéÑо¿Ê¹Ó㬲»µÃÓÃÓÚÁÙ´²Õï¶Ï¡¢ÖÎÁƵÈÁìÓò¡£
µ±ÊÕµ½Ï¸°ûºó£¬Çë×ÐϸÔĶÁϸ°ûʹÓÃ˵Ã÷Ê飬°´¹æ¶¨²Ù×÷²¢¼Ç¼ϸ°û״̬£¨ÅÄÕÕ£©¡£ÎÒ˾Ϊ¿Í»§ÌṩһÖÜÄÚµÄÊÛºó±£ÕÏ¡£
²Î¿¼ÎÄÏ×
Qing Y, et al. Inhibitory effects of iron on bone morphogenetic protein 2-induced osteoblastogenesis. J. Bone Miner. Res. 26(6): 1188-1196, 2011. PubMed: 21308772
Chow YH, et al. Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2. J. Virol. 71: 169-178, 1997. PubMed: 8985336
Hsu DK, et al. Identification of a murine TEF-1-related gene expressed after mitogenic stimulation of quiescent fibroblasts and during myogenic differentiation. J. Biol. Chem. 271: 13786-13795, 1996. PubMed: 8662936
Kessler PD, et al. Gene delivery to skeletal muscle results in sustanined expression and systemic delivery of a therapeutic protein. Proc. Natl. Acad. Sci. USA 93: 14082-14087, 1996. PubMed: 8943064
Katagiri T, et al. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage [published erratum appears in J Cell Biol 1995 Feb;128(4):following 713]. J. Cell Biol. 127: 1755-1766, 1994. PubMed: 7798324
±¾²úÎï½öÏÞÓÚ¿ÆÑ§ÊµÑéÑо¿Ê¹Ó㬲»µÃÓÃÓÚÁÙ´²Õï¶Ï¡¢ÖÎÁƵÈÁìÓò¡£
²úÎï×Éѯ
µç»°
΢ÐÅ×Éѯ
¹Ø×¢¹«ÖÚºÅ